194 related articles for article (PubMed ID: 31975352)
1. Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study.
Sumaya W; Wallentin L; James SK; Siegbahn A; Gabrysch K; Himmelmann A; Ajjan RA; Storey RF
Thromb Haemost; 2020 Mar; 120(3):412-422. PubMed ID: 31975352
[TBL] [Abstract][Full Text] [Related]
2. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.
Sumaya W; Wallentin L; James SK; Siegbahn A; Gabrysch K; Bertilsson M; Himmelmann A; Ajjan RA; Storey RF
Eur Heart J; 2018 Apr; 39(13):1078-1085. PubMed ID: 29390064
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Andell P; James SK; Cannon CP; Cyr DD; Himmelmann A; Husted S; Keltai M; Koul S; Santoso A; Steg PG; Storey RF; Wallentin L; Erlinge D;
J Am Heart Assoc; 2015 Oct; 4(10):e002490. PubMed ID: 26452988
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.
Hagström E; James SK; Bertilsson M; Becker RC; Himmelmann A; Husted S; Katus HA; Steg PG; Storey RF; Siegbahn A; Wallentin L;
Eur Heart J; 2016 Apr; 37(16):1325-33. PubMed ID: 26417057
[TBL] [Abstract][Full Text] [Related]
6. Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice.
Mullen L; Meah MN; Elamin A; Aggarwal S; Shahzad A; Shaw M; Hasara J; Rashid M; Fisher M; Ali T; Patel B; Ding WY; Grainger R; Heseltine T; Kirmani BH; Obeidat M; Kasolo Y; Thatchil J; Khand A
J Am Heart Assoc; 2021 Apr; 10(8):e019467. PubMed ID: 33834845
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
Ueland T; Åkerblom A; Ghukasyan T; Michelsen AE; Aukrust P; Becker RC; Bertilsson M; Himmelmann A; James SK; Siegbahn A; Storey RF; Kontny F; Wallentin L;
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29330256
[TBL] [Abstract][Full Text] [Related]
8. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP
Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305
[TBL] [Abstract][Full Text] [Related]
9. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Mahaffey KW; Held C; Wojdyla DM; James SK; Katus HA; Husted S; Steg PG; Cannon CP; Becker RC; Storey RF; Khurmi NS; Nicolau JC; Yu CM; Ardissino D; Budaj A; Morais J; Montgomery D; Himmelmann A; Harrington RA; Wallentin L;
J Am Coll Cardiol; 2014 Apr; 63(15):1493-9. PubMed ID: 24561148
[TBL] [Abstract][Full Text] [Related]
10. Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
Batra G; Lindbäck J; Becker RC; Harrington RA; Held C; James SK; Kempf T; Lopes RD; Mahaffey KW; Steg PG; Storey RF; Swahn E; Wollert KC; Siegbahn A; Wallentin L
J Am Coll Cardiol; 2022 Nov; 80(18):1735-1747. PubMed ID: 36302586
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial.
Husted S; James S; Becker RC; Horrow J; Katus H; Storey RF; Cannon CP; Heras M; Lopes RD; Morais J; Mahaffey KW; Bach RG; Wojdyla D; Wallentin L;
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):680-8. PubMed ID: 22991347
[TBL] [Abstract][Full Text] [Related]
12. Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Åkerblom A; Wojdyla DM; Wallentin L; James SK; de Souza Brito F; Steg PG; Cannon CP; Katus HA; Himmelmann A; Storey RF; Becker RC; Lopes RD;
Am Heart J; 2019 Jul; 213():57-65. PubMed ID: 31108273
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
Neergaard-Petersen S; Larsen SB; Grove EL; Kristensen SD; Ajjan RA; Hvas AM
Thromb Haemost; 2020 Jan; 120(1):75-82. PubMed ID: 31733633
[TBL] [Abstract][Full Text] [Related]
14. Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
Gregersen I; Michelsen AE; Lunde NN; Åkerblom A; Lakic TG; Skjelland M; Ryeng Skagen K; Becker RC; Lindbäck J; Himmelmann A; Solberg R; Johansen HT; James SK; Siegbahn A; Storey RF; Kontny F; Aukrust P; Ueland T; Wallentin L; Halvorsen B
J Am Heart Assoc; 2020 Sep; 9(17):e016360. PubMed ID: 32809893
[TBL] [Abstract][Full Text] [Related]
15. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.
Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA
J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.
James S; Budaj A; Aylward P; Buck KK; Cannon CP; Cornel JH; Harrington RA; Horrow J; Katus H; Keltai M; Lewis BS; Parikh K; Storey RF; Szummer K; Wojdyla D; Wallentin L
Circulation; 2010 Sep; 122(11):1056-67. PubMed ID: 20805430
[TBL] [Abstract][Full Text] [Related]
17. Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study.
Gue YX; Memtsas V; Kanji R; Wellsted DM; Busby A; Smith M; Vilar E; Ryding A; Arachchillage DJ; Gorog DA
Thromb Res; 2024 Apr; 236():144-154. PubMed ID: 38447421
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
Gimbel M; Qaderdan K; Willemsen L; Hermanides R; Bergmeijer T; de Vrey E; Heestermans T; Tjon Joe Gin M; Waalewijn R; Hofma S; den Hartog F; Jukema W; von Birgelen C; Voskuil M; Kelder J; Deneer V; Ten Berg J
Lancet; 2020 Apr; 395(10233):1374-1381. PubMed ID: 32334703
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
